Theranostics · 2020 · 51 citations · 31 references
MedicineMolecular BiologyOncologyCellular MetabolismMolecular OncologyTumor ProgressionCancer MetabolismGlycogen MetabolismKidney CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerRenal Cell CarcinomaClinical Significance AssessmentGlycogen AccumulationGlycogen AnalysisGlycogen DegradationGlycogen Synthase Kinase RegulationGlycolysis In Cancer MetabolismNf-κb Signaling
Our study findings reveal an oncogenic role for GYS1 in cell proliferation and glycogen metabolism in ccRCC. Re-sensitization of ccRCC cells to sunitinib suggests that GYS1 is a useful indicator of unfavorable prognosis as well as a therapeutic target for patients with ccRCC.
31
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi, Ed Reznik, Chung‐Han Lee et al. · Cancer Cell · 2016 · 854 citations · Full text
Medicine, Cell Biology, Oncology +14
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li, Bo Qiu, David S.M. Lee et al. · Nature · 2014 · 540 citations